About Us
Oxford MEStar Limited is a young spin-out company from the Institute of Biomedical Engineering of Oxford University.
In December 2013 we received £1M investment and another £1.1M in July 2015 from the private sector. Our head office is located at the Oxford Science Park, in the Magdalen Centre .
What do we do?
Oxford MEStar provides bioengineering products and solutions to serve translational and regenerative medicine, brings bio-business from the UK to China and develops wearable device technology within the healthcare industry.
What do we specialise in?
With our core technical expertise in bioprocessing, bioengineering and bio-manufacture, we have developed enabling technologies for tissue engineering and stem cell therapy. We are also able to reach an extensive network of investors, bio-tech businesses, GMP manufacturing facilities, and marketing and distribution channels in China.
One of the unique strengths of Oxford MEStar lies in our ability to quickly respond to market demands, and offer practical solutions to our clients for their product improvements. Combining our technical expertise and ease of access to the market, we are actively seeking opportunities for bringing bio-business from the UK to China.
Prof Zhanfeng Cui，FREng
Chairman & Founder
Oxford MEStar was founded by Prof Z. F. Cui in 2013. Prof Cui is the Donald Pollock Professor of Chemical Engineering at the University of Oxford, founding director of the Oxford Centre for Tissue Engineering and Bioprocessing, a Fellow of the Royal Academy of Engineering (RAE), and a Professorial Fellow of Hertford College. Prof Cui is well known in tissue engineering, bioseparation, bioprocessing and membrane technology.
Professor Cui made a name for himself as a successful start-up entrepreneur. He has founded three bio-tech companies in Oxford (CN Bio Innovations Ltd, previous known as Zyoxel Ltd, Oxford MEStar Ltd, and Oxsed Ltd), and helped to establish two high-tech companies in China (AK Biomedicals Ltd and Weikai Bioeng Ltd).